On Thursday shares of Abbott Laboratories (NYSE:ABT) closed at $48.67. Company’s sales growth for last 5 years was -8.00% and EPS growth for next 5 years is recorded as 9.70%. Abbott Laboratories (NYSE:ABT) Effective June 1, 2015,Thomas C. Freyman has been appointed Executive Vice President, Finance and Administration; John M. Capek has been appointed Executive Vice President, Ventures; and, Brian B. Yoor, has been appointed Senior Vice President, Finance and Chief Financial Officer, and will continue to report to Mr. Freyman in his new role.
SeaDrill Limited (NYSE:SDRL) in last trading activity fell -6.13% to close at $14.08. Company weekly performance is 5.31% while its quarterly performance stands at 8.14%. SeaDrill Limited (NYSE:SDRL) is -64.23% away from its 52 week high. SeaDrill Limited (NYSE:SDRL) has slated to release earnings on May 27.
On last trading day Pioneer Natural Resources Co. (NYSE:PXD) moved up 0.89% to close at $153.24. Its volatility for the week is 3.16% while volatility for the month is 3.00%. PXD’s sales growth for past 5 years was 23.50% and its EPS growth for past 5 years was 49.20%. Pioneer Natural Resources Co. (NYSE:PXD) monthly performance is -14.84%. Pioneer Natural Resources Company (NYSE:PXD) on 5 May, announced financial and operating results for the quarter ended March 31, 2015. Pioneer reported a first quarter net loss attributable to common stockholders of $78 million, or $0.52 per diluted share. Without the effect of noncash derivative mark-to-market gains and other unusual items, adjusted income for the first quarter was a loss of $5 million after tax, or $0.03 per diluted share.
On Thursday shares of Johnson & Johnson (NYSE:JNJ) closed at $101.83. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.13%. Johnson & Johnson (NYSE:JNJ) and Actavis plc (NYSE:ACT) have been cleared of any wrongdoing after being accused of not doing enough to warn patients of addiction risks posed by their prescription pain killers on sale. However, Purdue Pharma will have to make its case after a U.S District Court concluded it had a case to answer on the same issue.
On last trading day Heritage-Crystal Clean, Inc (NASDAQ:HCCI) moved up 1.31% to close at $13.16. Its volatility for the week is 5.66% while volatility for the month is 4.18%. HCCI’s sales growth for past 5 years was 28.10% and its EPS growth for past 5 years was -33.50%. Heritage-Crystal Clean, Inc (NASDAQ:HCCI) monthly performance is -3.87%. Heritage-Crystal Clean (NASDAQ:HCCI)‘s stock had its “hold” rating reaffirmed by Zacks in a research note issued on 1 May.